Benign salivary gland tumours

Author(s):  
Roderick Cawsony
1995 ◽  
Vol 109 (4) ◽  
pp. 343-345 ◽  
Author(s):  
A. Noghreyan ◽  
A. Gatot ◽  
E. Maor ◽  
D. M. Fliss

AbstractBenign salivary gland tumours in childhood are rare. We present a case of a pleomorphic adenoma arising in a minor salivary gland within the hard palate, review the literature and discuss the diagnostic and therapeutic features of the condition.


Dental Update ◽  
2019 ◽  
Vol 46 (7) ◽  
pp. 684-685
Author(s):  
Amandeep Bains ◽  
Thomas Dennis ◽  
Dimtrios Doumpiotis

This case report demonstrates the management of a myoepithelioma in the minor salivary glands of the palate. Myoepitheliomas are rare, benign, salivary gland tumours which usually affect the parotid glands. The rare neoplasms only account for 1–1.5% of all salivary gland neoplasms. This case shows a minimal approach to treating this rare tumour found in a rare site. CPD/Clinical Relevance: This case demonstrates the potential for rapid epithelial recovery within the oral cavity.


Author(s):  
Ananthaneni Anuradha ◽  
Undavalli Suresh Babu ◽  
Penumala Vignatha ◽  
Bagalad S. Bhavana

<p>Cystadenomas are rare benign salivary gland tumours characterised by prominent epithelium-lined papillary projections into the cystic spaces. Cystadenoma accounts for 2% of all salivary gland tumors, occurring most commonly in major salivary glands. Histopathologically there are two variants, papillary and mucinous variant. However very few cases are being reported in literature. We report a case of papillary cystadenoma occuring in parotid gland in a 28 year old male patient. Clinically, it presents as a soft, fluctuant, sessile and non-tender swelling measuring about 4×3.5 cm in diameter. Excisional biopsy was performed. The histopathological features were characteristic of papillary cystadenoma. This article highlights its clinical and histopathological features along with review of literature. </p>


2018 ◽  
Vol 2018 ◽  
pp. 1-8 ◽  
Author(s):  
Pawel Sowa ◽  
Karolina Goroszkiewicz ◽  
Joanna Szydelko ◽  
Joanna Chechlinska ◽  
Katarzyna Pluta ◽  
...  

Salivary gland tumours represent about 6% of head and neck neoplasms and about 0.5% of all malignancies in humans. Tumour growth and malignant transformation are complex processes involving various actions of molecules. Furthermore, some malignant salivary gland tumours are deemed to be caused by dedifferentiation or malignant transformation of benign tumours. The mechanisms of this transformation depend on a variety of different elements, such as cell cycle regulators, oncogenes, proteins, angiogenesis factors, and adipocytokines. The authors used PubMed, Medline, and Google websites to find and review the most significant papers related to malignant transformation in benign salivary gland tumours.


1999 ◽  
Vol 8 (3) ◽  
pp. 201-212
Author(s):  
Mohi Al-Tamami ◽  
Nail Al-Naqeeb ◽  
Agnes Kovacs ◽  
Hussein Dashti ◽  
John Madda Patrick

Author(s):  
Edward Balai ◽  
Navdeep Bhamra ◽  
Karan Jolly

Salivary gland tumours are uncommon and account for just 6% of all head and neck neoplasms. Worldwide incidence varies, from 0.4 to 13.5 cases per 100 000 population. The parotid gland is by far the most commonly affected site, accounting for 80% of cases. The vast majority of these tumours are benign; only approximately 20–25% being malignant. This article considers the relevant clinical anatomy of the parotid gland, key aspects of assessment with history and examination, and when to refer to secondary care for further investigation. It will touch on the common benign and malignant parotid neoplasms and give an overview of secondary care management.


Sign in / Sign up

Export Citation Format

Share Document